Heron Therapeutics (HRTX) Return on Equity [ROE] (2009 - 2026)
Heron Therapeutics' Return on Equity [ROE] was -135.42% in Q2 2026, down 46.31 percentage points from the prior quarter.
Powered by 
Analysis
Heron Therapeutics (HRTX) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For FY2022, Return on Equity [ROE] at Heron Therapeutics came in at -385.10%, down 245.12 percentage points from FY2021.
- Return on Equity [ROE] has now declined for three consecutive years, with a five-year change of -25.73 percentage points (FY2017 to FY2022).
- In earlier years, Return on Equity [ROE] was -139.98% in FY2021 (-69.25 pp), -70.72% in FY2020 (-17.78 pp), -52.95% in FY2019 (+19.12 pp) and -72.07% in FY2018 (+287.30 pp).
- The Q2 2026 figure marks the lowest quarterly Return on Equity [ROE] since Q1 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Heron Therapeutics | 70.40 Mn | -87.13 Mn | 26.29 Mn | -364.80% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -364.80% |
| Jun 30, 2026 | -424.48% |
| Mar 31, 2026 | -263.72% |
| Dec 31, 2025 | -138.30% |
| Mar 31, 2023 | -14,081.85% |
| Dec 31, 2022 | -1,010.70% |
| Sep 30, 2022 | -60,743.42% |
| Jun 30, 2022 | -20,463.82% |
| Mar 31, 2022 | -457.19% |
| Dec 31, 2021 | -224.98% |
| Sep 30, 2021 | -164.09% |
| Jun 30, 2021 | -131.93% |
| Mar 31, 2021 | -105.80% |
| Dec 31, 2020 | -88.43% |
| Sep 30, 2020 | -74.01% |
| Jun 30, 2020 | -57.28% |
| Mar 31, 2020 | -50.08% |
| Dec 31, 2019 | -59.36% |
| Sep 30, 2019 | -66.43% |
| Jun 30, 2019 | -63.08% |
API Access
Heron Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=HRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "HRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=HRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();